Back to top
Bionomics (BNOX)
(Delayed Data from NSDQ)
$0.27 USD
0.27
694,360
-0.01 (-4.48%)
Updated Oct 7, 2024 03:59 PM ET
After-Market: $0.26 -0.01 (-4.80%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
View All Zacks #1 Ranked Stocks
Income Statements
Fiscal Year end for Bionomics Limited Unsponsored ADR falls in the month of June .
All items in Millions except EPS data.
| 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | NA |
| Cost Of Goods | 0 | 0 | 0 | 0 | NA |
| Gross Profit | 0 | 0 | 0 | 0 | NA |
| Selling & Adminstrative & Depr. & Amort Expenses | 18 | 22 | 16 | 6 | 0 |
| Income After Depreciation & Amortization | -18 | -22 | -16 | -6 | 0 |
| Non-Operating Income | 2 | 0 | 0 | 0 | NA |
| Interest Expense | 0 | 0 | 0 | 1 | NA |
| Pretax Income | -16 | -22 | -16 | -7 | NA |
| Income Taxes | 0 | 0 | 0 | 0 | NA |
| Minority Interest | 0 | 0 | 0 | 0 | NA |
| Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
| Other Income/Charges | 0 | 0 | 0 | 0 | NA |
| Income From Cont. Operations | -15 | -21 | -16 | -7 | NA |
| Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
| Net Income (GAAP) | -15 | -21 | -16 | -7 | NA |
| Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
|---|---|---|---|---|---|
| Income Before Depreciation & Amortization | -17 | -21 | -15 | -4 | 0 |
| Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | NA |
| Income After Depreciation & Amortization | -18 | -22 | -16 | -6 | 0 |
| Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
|---|---|---|---|---|---|
| Average Shares | 9.99 | 8.16 | 7.52 | NA | NA |
| Diluted EPS Before Non-Recurring Items | -1.77 | -2.42 | -2.61 | NA | NA |
| Diluted Net EPS (GAAP) | -1.55 | -2.63 | -2.61 | -1.34 | NA |
Fiscal Year end for Bionomics Limited Unsponsored ADR falls in the month of June .
All items in Millions except EPS data.
| 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
|---|---|---|---|---|---|
| Sales | NA | NA | NA | NA | NA |
| Cost Of Goods | NA | NA | NA | NA | NA |
| Gross Profit | NA | NA | NA | NA | NA |
| SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Operating Income | NA | NA | NA | NA | NA |
| Interest Expense | NA | NA | NA | NA | NA |
| Pretax Income | NA | NA | NA | NA | NA |
| Income Taxes | NA | NA | NA | NA | NA |
| Minority Interest | NA | NA | NA | NA | NA |
| Investment Gains/Losses | NA | NA | NA | NA | NA |
| Other Income/Charges | NA | NA | NA | NA | NA |
| Income From Cont. Operations | NA | NA | NA | NA | NA |
| Extras & Discontinued Operations | NA | NA | NA | NA | NA |
| Net Income (GAAP) | NA | NA | NA | NA | NA |
| Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
|---|---|---|---|---|---|
| Average Shares | NA | NA | NA | NA | NA |
| Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
| Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |